Aurora Cannabis (ACB.TO) Stock Soars on CBD Buzz: In-Depth Analysis & 2025 Outlook
Aurora Cannabis trades at C$6.85 on the TSX, valuing the company at about C$390 million. The stock surged over 25% in late September after Donald Trump backed CBD and hinted at U.S. marijuana rescheduling. Medical cannabis sales rose 37% year-over-year to C$65 million in fiscal Q1 2026, driving positive adjusted EBITDA. Aurora reports Q2 earnings Nov. 5, with analysts expecting C$63 million in revenue.
